Cort Olsen

The online retail giant’s purchase of the drug delivery service could mean the end of pharmacy benefit managers and a major wake up call for benefit brokers, says Shandon Fowler.

An advertisement by Blue Cross Blue Shield of North Carolina has sparked debate among advisers nationwide, leaving them to ask who is really paying the broker and is anyone on the side of the employer.

Injectable drugs and in-patient care drive the highest of cost for employers.

Health savings account participants are more engaged in their healthcare decisions but still see HSAs as ways for reducing medical expense.

In an effort to bring insurance carriers back to ACA exchanges, the U.S. government is increasing funding to insurers, which could spur brokers to recommend the exchanges to clients.